Trial intelligence / Profile preview

Epoetin beta after kidney transplantation for renal function and anemia

2007-002562-35Phase 3Active

Sponsor
CHU Amiens-Picardie
Start
Jul 2007
Modality
Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, open-label trial of epoetin beta in anemia of chronic kidney disease (2 arms), sponsored by CHU Amiens-Picardie. Started Jul 2007; status: active.

02

Drugs

epoetin beta
03

Conditions

anemia of chronic kidney disease

Beyond the preview

Go deeper on 2007-002562-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002562-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call